SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-442128
Filing Date
2013-11-14
Accepted
2013-11-14 16:16:49
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d585605d10q.htm 10-Q 567261
2 EX-31.1 d585605dex311.htm EX-31.1 8710
3 EX-31.2 d585605dex312.htm EX-31.2 8692
4 EX-32.1 d585605dex321.htm EX-32.1 3529
5 EX-32.2 d585605dex322.htm EX-32.2 3394
  Complete submission text file 0001193125-13-442128.txt   4325155

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT petx-20130930.xml EX-101.INS 495780
7 XBRL TAXONOMY EXTENSION SCHEMA petx-20130930.xsd EX-101.SCH 47351
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE petx-20130930_cal.xml EX-101.CAL 58651
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE petx-20130930_def.xml EX-101.DEF 198222
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE petx-20130930_lab.xml EX-101.LAB 354594
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE petx-20130930_pre.xml EX-101.PRE 278617
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35952 | Film No.: 131220220
SIC: 2834 Pharmaceutical Preparations